BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11297853)

  • 1. Bactericidal properties of the chloroform fraction from rhizomes of Aristolochia paucinervis Pomel.
    Gadhi CA; Hatier R; Mory F; Marchal L; Weber M; Benharref A; Jana M; Lozniewski A
    J Ethnopharmacol; 2001 May; 75(2-3):207-12. PubMed ID: 11297853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of Aristolochia paucinervis Pomel.
    Gadhi CA; Weber M; Mory F; Benharref A; Lion C; Jana M; Lozniewski A
    J Ethnopharmacol; 1999 Oct; 67(1):87-92. PubMed ID: 10616964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Helicobacter pylori activity of Aristolochia paucinervis Pomel extracts.
    Gadhi CA; Benharref A; Jana M; Lozniewski A
    J Ethnopharmacol; 2001 May; 75(2-3):203-5. PubMed ID: 11297852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible monensin adaptation in Enterococcus faecium, Enterococcus faecalis and Clostridium perfringens of cattle origin: potential impact on human food safety.
    Simjee S; Heffron AL; Pridmore A; Shryock TR
    J Antimicrob Chemother; 2012 Oct; 67(10):2388-95. PubMed ID: 22740589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of anti-bacterial activity of medicinal plants from Belize (Central America).
    Camporese A; Balick MJ; Arvigo R; Esposito RG; Morsellino N; De Simone F; Tubaro A
    J Ethnopharmacol; 2003 Jul; 87(1):103-7. PubMed ID: 12787962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations.
    Tsuji BT; Bulitta JB; Brown T; Forrest A; Kelchlin PA; Holden PN; Peloquin CA; Skerlos L; Hanna D
    J Antimicrob Chemother; 2012 Sep; 67(9):2182-90. PubMed ID: 22685161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of crude methanolic extract and its fractions of aerial parts of Anthemis tinctoria.
    Akgul C; Saglikoglu G
    Indian J Biochem Biophys; 2005 Dec; 42(6):395-7. PubMed ID: 16955742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo pharmacokinetic/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits.
    Zhou YF; Yu Y; Sun J; Tao MT; Zhou WJ; Li X; Liao XP; Liu YH
    Anaerobe; 2016 Jun; 39():150-7. PubMed ID: 27060276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safe enterocin DD14 is a leaderless two-peptide bacteriocin with anti-Clostridium perfringens activity.
    Caly DL; Chevalier M; Flahaut C; Cudennec B; Al Atya AK; Chataigné G; D'Inca R; Auclair E; Drider D
    Int J Antimicrob Agents; 2017 Mar; 49(3):282-289. PubMed ID: 28104423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci.
    Baltch AL; Smith RP; Ritz WJ; Bopp LH
    Chemotherapy; 2001; 47(4):250-60. PubMed ID: 11399861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial Effect of Azadirachta indica (Neem) or Curcuma longa (Turmeric) against Enterococcus faecalis Compared with That of 5% Sodium Hypochlorite or 2% Chlorhexidine in vitro.
    Joy Sinha D; D S Nandha K; Jaiswal N; Vasudeva A; Prabha Tyagi S; Pratap Singh U
    Bull Tokyo Dent Coll; 2017; 58(2):103-109. PubMed ID: 28724858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of aqueous and hydroalcoholic extracts of Acanthospermum australe (Loefl.) Kuntze against diarrhea-inducing bacteria.
    Mallmann R; Ethur EM; Bianchetti P; Faleiro D; Hoehne L; Goettert MI
    Braz J Biol; 2018 Nov; 78(4):619-624. PubMed ID: 29319752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of Amazon plant extracts against Enterococcus faecalis.
    de Castilho AL; da Silva JP; Saraceni CH; Díaz IE; Paciencia ML; Varella AD; Suffredini IB
    Braz J Microbiol; 2014; 45(3):769-79. PubMed ID: 25477906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
    Allen GP; Bierman BC
    Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.
    Kussmann M; Schuster L; Zeitlinger M; Pichler P; Reznicek G; Wiesholzer M; Burgmann H; Poeppl W
    Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2257-63. PubMed ID: 26337433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Enterococcus faecalis superoxide dismutase is essential for its tolerance to vancomycin and penicillin.
    Bizzini A; Zhao C; Auffray Y; Hartke A
    J Antimicrob Chemother; 2009 Dec; 64(6):1196-202. PubMed ID: 19828491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brodimoprim synergy against Enterococcus faecalis evaluated in vitro.
    Richards RM; Xing JZ
    J Antimicrob Chemother; 1996 Jul; 38(1):27-37. PubMed ID: 8858454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.